CN1052162C - Production method of traditional Chinese medicine pills for hyperostosis - Google Patents
Production method of traditional Chinese medicine pills for hyperostosis Download PDFInfo
- Publication number
- CN1052162C CN1052162C CN95112199A CN95112199A CN1052162C CN 1052162 C CN1052162 C CN 1052162C CN 95112199 A CN95112199 A CN 95112199A CN 95112199 A CN95112199 A CN 95112199A CN 1052162 C CN1052162 C CN 1052162C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- radix angelicae
- hyperosteogeny
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a preparation method of traditional Chinese medicine pills for treating hyperosteogeny. The traditional Chinese medicine pills are prepared from 14 to 18 wt% of angelica, 15 to 19 wt% of twotoothed achyranthes root, 13 to 17 wt% of doubleteeth pubesscent angelica root, 13 to 17 wt% of red peony root, 13 to 18 wt% of flastem milkvetch seed and 16 to 17 wt% of ivory. The traditional Chinese medicine pills prepared by the method have obvious effect of treating hyperosteogeny.
Description
The invention belongs to the manufacture method of medicine, be specially a kind of manufacture method for the treatment of the Chinese medicine pill of hyperosteogeny.
At present, hyperosteogeny has become common disease, particularly, old people's sickness rate is higher, hyperosteogeny is a kind of regression phenomenon after sclerotin wears out, in case suffer from hyperosteogeny, its hyperosteogeny part just can pressuring nerve, blood vessel or other tissue and cause uncomfortable sensations such as human body pain, numbness, and severe patient can cause can't take care of oneself, even paralysis.To this, many medical institutions have all offered the outpatient service of treatment hyperosteogeny, the way of common treatment hyperosteogeny is to adopt operation method that hypertrophy is partly cut a hole, but the position that operation back is gone by cutter is hypertrophy slowly also, even it is even more serious, though therefore adopt operation method can remove patient's short-term misery, can not effect a radical cure.Though it is for the moment painful that other Therapeutic Method such as traction, physical therapy, sealing, massage, acupuncture etc. can make the patient remove, can not realize the task of effecting a radical cure, still a kind of effect method or medicine for the treatment of hyperosteogeny found at the end at present.
A kind of oral honeyed pill that it promptly is raw material with the plurality of Chinese that task of the present invention is to provide a kind of manufacture method with Chinese medicine pill that is exclusively used in the treatment hyperosteogeny of significant curative effect, make with distinctive proportioning and easy processing technique.
Task of the present invention realizes with following scheme:
The raw material that the present invention selects for use is: Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Radix Angelicae Pubescentis, Radix Paeoniae Rubra, Semen Astragali Complanati, Dens Elephatis, and through Chinese medicine select materials, clean, dry, pulverize, sieve, mixing, one-tenth ball operation method and make.
Of the present invention in each medicine shared percentage by weight in gross weight be: Radix Angelicae Sinensis 14-18%, Radix Achyranthis Bidentatae 15-19%, Radix Angelicae Pubescentis 13-17%, Radix Paeoniae Rubra 13-17%, Semen Astragali Complanati 13-18%, Dens Elephatis 16-17%.
Manufacture method of the present invention is: prepared burden by the shared percentage by weight metering in accumulated dose of its each composition in the selected back of above-mentioned each Chinese medicine, each composition after the batching is put into water purification to be cleaned to clean, each Chinese medicinal ingredients after the cleaning is put into drying plant dries, after pulverizing and screen method, make it form the powdered raw material again, become ball after its powdered raw material and discharging the water pathogen part after refining reached Mel mixing more than 98%, be the Chinese medicine pill that the present invention treats hyperosteogeny.
Further describe as follows below with reference to embodiment to the manufacture method of the Chinese medicine pill of treatment hyperosteogeny of the present invention:
Embodiment 1
Each Chinese medicine ingredients shared percentage by weight in accumulated dose is:
Radix Angelicae Sinensis 17%, Radix Achyranthis Bidentatae 18%, Radix Angelicae Pubescentis 16%, Radix Paeoniae Rubra 15%, Semen Astragali Complanati 17%, Dens Elephatis 17%.
Embodiment 2
Each Chinese medicine ingredients shared percentage by weight in accumulated dose is:
Radix Angelicae Sinensis 18%, Radix Achyranthis Bidentatae 19%, Radix Angelicae Pubescentis 17%, Radix Paeoniae Rubra 13%, Semen Astragali Complanati 16.5%, Dens Elephatis 16.5%.
Embodiment 3
Each Chinese medicine ingredients shared percentage by weight in accumulated dose is:
Radix Angelicae Sinensis 16.5%, Radix Achyranthis Bidentatae 17.5%, Radix Angelicae Pubescentis 16.5%, Radix Paeoniae Rubra 16.5%, Semen Astragali Complanati 16.5%, Dens Elephatis 16.5%.
The manufacture method of the various embodiments described above and manufacture method of the present invention are identical, and wherein embodiment 3 is a most preferred embodiment of the present invention.
Utilize the present invention to treat the produced Chinese medicine pill of manufacture method of Chinese medicine pill of hyperosteogeny through 100 routine clinical trials, with 36 days be a course of treatment, be that 11 gram weight are dosage with every ball, sooner or later respectively take 1 ball every day, take 1 course of treatment continuously, cure rate reaches 96%.
In sum, the produced Chinese medicine pill of manufacture method that adopts the present invention to treat the Chinese medicine pill of hyperosteogeny has significant curative effect for the treatment hyperosteogeny, can effectively realize task of the present invention.
Claims (2)
1, a kind of manufacture method for the treatment of the Chinese medicine pill of hyperosteogeny comprises that Chinese medicine is selected materials, cleans, dries, pulverizes, sieved, mixing, one-tenth ball process, it is characterized in that:
A, Chinese medicine select materials into;
Radix Angelicae Sinensis, Radix Achyranthis Bidentatae, Radix Angelicae Pubescentis, Radix Paeoniae Rubra, Semen Astragali Complanati, Dens Elephatis;
B, each herbal species shared percentage by weight in gross weight is: Radix Angelicae Sinensis 14-18%, Radix Achyranthis Bidentatae 15-19%, Radix Angelicae Pubescentis 13-17%, Radix Paeoniae Rubra 13-17%, Semen Astragali Complanati 13-18%, Dens Elephatis 16-17%.
2, a kind of manufacture method for the treatment of the Chinese medicine pill of hyperosteogeny according to claim 1 is characterized in that said mixing method is: the dusty raw materials that each composition of Chinese medicine is formed after cleaning, dry, pulverize, sieving and discharging the water pathogen part after refining reach the Mel mixing more than 98%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95112199A CN1052162C (en) | 1995-11-03 | 1995-11-03 | Production method of traditional Chinese medicine pills for hyperostosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN95112199A CN1052162C (en) | 1995-11-03 | 1995-11-03 | Production method of traditional Chinese medicine pills for hyperostosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1133188A CN1133188A (en) | 1996-10-16 |
| CN1052162C true CN1052162C (en) | 2000-05-10 |
Family
ID=5079396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN95112199A Expired - Fee Related CN1052162C (en) | 1995-11-03 | 1995-11-03 | Production method of traditional Chinese medicine pills for hyperostosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1052162C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104928200B (en) * | 2014-03-17 | 2018-01-19 | 青岛科技大学 | There is bacillus marinus and the application of multiple functions to plant |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1083377A (en) * | 1993-01-16 | 1994-03-09 | 金河 | Yaojingkang (drug for curing lumbar and cervical diseases) |
-
1995
- 1995-11-03 CN CN95112199A patent/CN1052162C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1083377A (en) * | 1993-01-16 | 1994-03-09 | 金河 | Yaojingkang (drug for curing lumbar and cervical diseases) |
Non-Patent Citations (3)
| Title |
|---|
| 南通医学院学报1991,11(2) 1991.2.28 张银凤等，复方中药离子导入治疗骨质增生500例报告 * |
| 湖北中医杂志1993,15(1) 1993.1.31 陈华丰，芒针与药物透入法治疗骨质增生464例 * |
| 湖北中医杂志1993,15(1) 1993.1.31 陈华丰，芒针与药物透入法治疗骨质增生464例;南通医学院学报1991,11(2) 1991.2.28 张银凤等，复方中药离子导入治疗骨质增生500例报告 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1133188A (en) | 1996-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100473411C (en) | Pure traditional Chinese medicine preparation for treating hemiparalysis | |
| CN1086429A (en) | The compound method of hard paralysed health | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN1212127C (en) | Medicated sanitary article for treating gynopathy and its preparation | |
| CN1052162C (en) | Production method of traditional Chinese medicine pills for hyperostosis | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN1748746A (en) | Chinese medicinal preparation for treating rheumatism, rheumatoid and hyperosteogeny and preparing method | |
| CN1351872A (en) | Chinese herbal medicine for curing comedo and acne | |
| CN101352564B (en) | Novel medical use of pills for resuscitation and reconstruction | |
| CN1337246A (en) | Chinese medicine for treating cerebral thrombus sequelae | |
| CN1324650A (en) | Effective medicine for treating cervical vertebra disease as one kind of intractable disease | |
| CN1059327C (en) | Inflammation diminishing and asthma stopping cream | |
| CN1485063A (en) | Chinese traditional medicine formulation for rheumatism and its orthopaedic disease | |
| CN1060076C (en) | Gucixiao pill for removing spur | |
| CN1074114A (en) | Medical bathing powder for relieving fatigue and preparation technology thereof | |
| CN102048878A (en) | Plaster for assisting in treating rheumatic arthralgia and preparation method thereof | |
| CN101703716A (en) | Chinese medicinal preparation for treating polyneuritis | |
| CN1097618A (en) | Likangning for curing dysentery | |
| CN100402077C (en) | Medicinal composition for treating hyperosteogency | |
| CN1233331C (en) | Medicine for curing epilepsy by adopting head osmotic therapy | |
| CN1375320A (en) | Chinese medicine for treating hyperosteogeny and its prepn. | |
| CN1054052C (en) | Comedo-elimination preparation | |
| CN1433806A (en) | Medicated liquor for treating chronic osteonosus | |
| CN103386050B (en) | Chinese patent drug pill used for treating rheumatic ostealgia, cervical spondylosis and lumbar spondylosis | |
| CN1057692C (en) | Chinese patent drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |